SC 13G Filing

Company

Karyopharm Therapeutics Inc.

Filed

May 9, 2022

Accession Number

0001493152-22-012564

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →